North Coast Technology Investors
VC Fund
Ann Arbor, United States
North Coast Technology Investors is a VC fund in Ann Arbor focused on Software and Health Care. North Coast's capitalization allows them to see a promising venture through all stages of their private funding needs. Although they co-invest with other venture capital firms, and corporate partners, they are often the first or sole venture investor in the companies they back.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 25%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries North Coast Technology Investors invests in
Stages North Coast Technology Investors invests in
Countries North Coast Technology Investors invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hugo Braun
|
|||
Lindsay Aspegren
|
|||
|
Stephanie Shumacher
|
|||
2 more contacts available
Investment Focus
Industry
- Software 4 (20%)
- Health Care 4 (20%)
- Biotechnology 4 (20%)
- Medical 3 (15%)
- Information Technology 3 (15%)
Stage
- Series A 8 (40%)
- Funding Round 4 (20%)
- Series B 3 (15%)
- Series C 3 (15%)
- Seed 1 (5%)
Country
- United States 13 (65%)
- India 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Hugo Braun
Co-Founder & Partner
|
Co-Founder & Partner | Total investments: 5 | Find email | |
|
Lindsay Aspegren
General Partner
|
General Partner | Total investments: 4 | Find email | |
|
Stephanie Shumacher
Office Manager
|
Office Manager | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Delphinus Medical Technologies
|
Delphinus Medical Technologies develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presenceof benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan. | $30.4M / Series D / Sep 13, 2022 | |
Betterworks
|
Betterworks is a developer of cloud-based HR software used to align, develop, and activate the workforce for business growth. Its software offers continuous performance management programs that help in goal alignment, feedback, coaching, and development conversations necessary to inspire and motivate the entire workforce and enable enterprises toeasily set, measure, and cross-functionally align goals. | $51M / Series B / Mar 07, 2019 | |
BlueWillow Biologics
|
BlueWillow Biologics operates as a clinical-stage privately-held biopharmaceutical company. It focuses on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. Its platform employs novel oil-in-water nano-droplets for products administered to the skin andnose.The company was founded as a spin-off from the University of Michigan and is headquartered in Ann Arbor, Michigan. | $10M / Series A / May 07, 2018 | |
Impact Analytical
|
Impact Analytical is a contract testing laboratory supporting all phases of drug development and manufacturing, consumer products, medical device testing, plastics, specialty chemicals, packaging and automotive. They offer method development, validation, stability, extractables & leachables, problem solving, unknown identification, releasetesting, competitive analysis, failure analysis, raw material testing, surfactant analysis, and many other services. They have 30+ years of polymer and chemistry analysis experience. Impact Analytical is a GMP registered, GLP compliant (FDA, EPA), ISO 9001 certified, and DEA licensed. They are routinely audited by the FDA with no findings (483’s). Their customer-focused approach differentiates us in the industry and ensures you receive high quality results that are on-time and on-budget. Please contact us to schedule a facility audit and discuss your next project. | $3M / Dec 10, 2017 | |
AmpliFund
|
AmpliFund's cloud-based SaaS grant management solution (GMS) empowers funders and recipients to streamline process, centralize data and documentation, facilitate quantitative and qualitative reporting, and maximizing impact. We offer software for Grant Makers, Grant Seekers, and those managing the full grant Lifecycle as both the recipient andgrantor. AmpliFund exists to create a better world by simplifying business processes and amplifying grant resources to accelerate missions. Founded by grant management professionals who understood the value of technology and data, we help customers implement processes and software to amplify their impact. We know government grant management. We’ve shaped grant legislation, technology, and processes. Our state, local, and tribal customers rely on our tools, resources, and support to create capacity for their teams, drive compliance, and realize the full potential of their funding. | $10.5M / Series A / Oct 27, 2016 | |
|
Delphinus Medical Technologies
|
Delphinus Medical Technologies develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presenceof benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan. | $39.5M / Series C / Sep 10, 2015 | |
VNN
|
VNN is the largest and fastest growing high school sports marketing platform in America. As the exclusive web/mobile platform for over 7million passionate fans across 40+ states (adding 8,000 fans daily), VNN is rapidly aggregating the fragmented, multi-billion dollar high school sports market onto an intelligent platform that transforms theconsumer experience of high school sports. | $3.7M / Sep 03, 2015 | |
Larky
|
Larky is a mobile and web platform that helps organizations connect with their audiences at the right time and place. Clients include banks, credit unions, health insurance providers, employers, universities and more. Larky serves clients in 20 US states and Canada. | Series A / Jun 06, 2014 | |
|
VNN
|
VNN is the largest and fastest growing high school sports marketing platform in America. As the exclusive web/mobile platform for over 7million passionate fans across 40+ states (adding 8,000 fans daily), VNN is rapidly aggregating the fragmented, multi-billion dollar high school sports market onto an intelligent platform that transforms theconsumer experience of high school sports. | $3M / Series A / Feb 17, 2014 | |
|
Delphinus Medical Technologies
|
Delphinus Medical Technologies develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presenceof benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan. | $11M / Series B / Sep 03, 2013 | |
| See all 20 investments → | |||
Co-Investors
Arboretum Ventures
5 deals together
Beringea
5 deals together
Apjohn ventures
3 deals together
Lurie Investment Fund
3 deals together
Michigan Angel Fund
3 deals together
Arsenal Growth Equity
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does North Coast Technology Investors invest in?
North Coast Technology Investors invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Funding Round stage. Most of the 20 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact North Coast Technology Investors?
Public channels for North Coast Technology Investors include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at North Coast Technology Investors?
The team at North Coast Technology Investors includes Hugo Braun (Co-Founder & Partner), Lindsay Aspegren (General Partner) and Stephanie Shumacher (Office Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
